Skip to main content
main-content

Sanjay Kalra

Sanjay Kalra, MBBS MD DM (AIIMS New Delhi), is an endocrinologist based at Bharti Hospital, Karnal, India. Former Executive Editor of the Indian Journal of Endocrinology & Metabolism (IJEM), he is currently Executive Editor of Thyroid Research and Practice (TRP), and Associate Editor of Diabetic Medicine (UK). He has worked as Principal Investigator in over 50 phase 1, 2 and 3 trials. As Vice President of the South Asian Federation of Endocrine Societies (SAFES), he works to spread endocrine and diabetes awareness in the region, and beyond. In his spare time, he indulges in his favorite hobby, the Punjabi folk dance bhangra.

Latest contributions from Sanjay Kalra

08-06-2019 | SGLT2 inhibitors | Editorial | Article

Cardiorenal syndromes and SGLT2 inhibitor usage

Sanjay Kalra explores the intrinsic link between the cardiovascular and renal systems, focusing on whether the SGLT2 inhibitor class has a role to play in diabetic patients with cardiorenal comorbidity.

05-22-2019 | Sulfonylureas | Editorial | Article

The CAROLINA trial: Make or break for sulfonylureas?

Diabetologist Sanjay Kalra puts the CAROLINA trial into historical context and considers the present-day implications for the use of DPP-4 inhibitors and sulfonylureas.

12-05-2018 | Diabetes distress | Editorial | Article

Diabetes distress: What’s in a name?

Sanjay Kalra and Psychiatrist Yatan Pal Singh Balhara question whether “diabetes distress” is well understood outside of the diabetes field and consider whether alternative terminology may help to bridge the knowledge gap.

11-14-2018 | Cardiovascular outcomes | Editorial | Article

What have I learned from cardiovascular outcome trials?

Endocrinologist Sanjay Kalra considers the impact that cardiovascular outcome trials have had on the standard of diabetes care and questions what else they might accomplish in the future.

Image Credits